Validation of the Korean Version of the SARC-F Questionnaire to Assess Sarcopenia: Korean Frailty and Aging Cohort Study
Validation of the Korean Version of the SARC-F Questionnaire to Assess Sarcopenia: Korean Frailty and Aging Cohort Study
复制标题
DOI：
10.1016/j.jamda.2017.07.006
复制
发表时间：
2018-01-01
影响因子：
7.6
通讯作者：
Won, Chang Won
中科院分区：
文献类型：
--
作者：
Kim, Sunyoung;Kim, Miji;Won, Chang Won
目的：SARC-F是一种简单的肌肉减少症筛查工具，包括5个评估项目：力量、辅助行走、从椅子上站起来、爬楼梯和跌倒。本研究旨在检验韩国版本的SARC-F对居住在社区的老年人的有效性。环境和参与者：从韩国衰弱和老龄化队列研究的第一年基线数据中，共有1222名符合研究选择标准的老年人（70岁及以上）被纳入分析。测量：SARC-F被翻译成韩国语，以一种文化响应的方式。总分由5个题目的得分相加计算。根据总分（SARC-F < 4 vs SARC-F >= 4）将参与者分为两组，并按性别考察其与步行速度、握力、日常活动能力、健康相关生活质量等因素的相关性。此外，通过将该工具与欧洲、国际和亚洲肌少症工作组的肌少症诊断标准进行比较，分析了该工具的有效性。结果：根据SARC-F，肌肉减少症的患病率男性为4.2%，女性为15.3%。与欧洲、国际和亚洲的肌少症诊断标准相比，SARC-F的敏感性较低[男性(M): 11%-60%，女性(F): 28%-34%]。然而，SARC-F具有高特异性（M: 96.6% ~ 98%, F: 85% ~ 87.7%）和高阴性预测值（M: 89.2% ~ 99.3%, F: 88.5% ~ 98.4%）。与src - f < 4组相比，src - f >= 4组的参与者握力较差，行走速度较慢，身体表现较差，认知功能较差，生活质量较低（EuroQol-5维度得分较高）。结论：韩文版SARC-F特异性高，阴性预测值高。因此，该工具在临床环境中可用于简单地排除肌肉减少症。此外，使用SARC-F诊断肌肉减少症被发现与身体表现、认知功能和生活质量有关。(C) 2017 AMDA -急性和长期护理医学学会。
Objectives: The SARC-F is a simple sarcopenia screening tool comprising 5 assessment items: strength, assistance walking, rising from a chair, climbing stairs, and falls. The present study aimed to examine the validation of the Korean version of SARC-F for elderly individuals residing in communities.Setting and Participants: From the first year baseline data of Korean Frailty and Aging Cohort Study, a total of 1222 elderly individuals (70 years and older) who met the study's selection criteria were included in the analysis.Measurements: The SARC-F was translated into the Korean language in a culturally responsive way. The total score was calculated by adding the scores on the 5 items. The participants were divided into 2 groups according to the total score (SARC-F < 4 vs SARC-F >= 4), and its correlations with various factors including walking speed, hand grip, ability to perform everyday activities, and health-related quality of life, were examined by sex. In addition, the tool's validity was analyzed by comparing it with the European, international, and Asian sarcopenia working group diagnostic criteria for sarcopenia.Results: The prevalence of sarcopenia according to the SARC-F was 4.2% in among men and 15.3% in women. The sensitivity of the SARC-F was low compared with the European, international, and Asian criteria of sarcopenia [male (M): 11%-60%, female (F): 28%-34%]. However, SARC-F showed a high specificity (M: 96.6%-98%, F: 85%-87.7%) and a high negative predictive value (M: 89.2%-99.3%, F: 88.5% -98.4%). The participants in the SARC-F >= 4 group had poorer grip strength, slower walking speed, poorer physical performance, poorer cognitive function, and a lower quality of life (a high EuroQol-5 dimension score) than the participants in the SARC-F < 4 group.Conclusions: The Korean language version of SARC-F showed a high specificity and high negative predictive value. As such, the tool is useful for briefly ruling out sarcopenia in a clinical setting. In addition, diagnosis of sarcopenia using the SARC-F was found to be associated with physical performance, cognitive function, and the quality of life. (C) 2017 AMDA - The Society for Post-Acute and Long-Term Care Medicine.